Approximately one year later, the Department of Gynecology and Obstetrics requested Genetic Counseling for a 33 years old woman, secondigravida (22° gestation week), with abnormal ultrasound findings showing severe fetal ventriculomegaly. The family history was unremarkable with no consanguinity; she was one of two sisters and had a healthy brother. Surprisingly the woman was the mother of our proband. On the basis of a diagnostic hypothesis of L1 syndrome (includes a spectrum of related neurological disorders with an X-linked recessive mode of inheritance), we performed molecular analysis on the proband's DNA, mother's DNA and fetal DNA. The mutational screening revealed the presence of a non sense c.2701C>T (p.Arg901*) mutation in the exon 20 of the L1CAM gene in all the tested DNA samples. This observation underline a necessity to consider L1-syndrome as potential part of differential diagnosis in all cases of hydrocephaly, same as undoubting of importance of genetic counseling with subsequent, extension of the molecular analysis to the relatives in order to provide an effective and reliable counseling and risk assessment to these families. Finally, the development of new analytical tools [primarily next generation sequencing (NGS)] and development of an assay/gene panel can be used to specifically target a L1 Syndrome for fast, reliable and high quality results in tricky clinical situation like this one.
Keywords: Hydrocephaly, L1 syndrome, L1CAM gene, pre-and post-natal diagnosis INTRODUCTION In middle 90's scientific community referred as CRASH syndrome, for clinical situation characterized by corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraplegia, and hydrocephalus (FRANSEN et al., 1995; KENWRICK et al., 1996) , even though this pathology is known as well as L1 syndrome. In fact, this syndrome represents a spectrum of related neurological disorders with an X-linked recessive mode of inheritance due to mutations in the human L1 cell adhesion molecule gene (L1CAM;OMIM 308840) which include: X-linked hydrocephalus with stenosis of the aqueduct of Sylvius (HSAS; OMIM 307000); mental retardation, adducted thumbs, shuffling gait, and aphasia (MASA) syndrome (OMIM 303350); spastic paraplegia type 1 (SP1; OMIM 312900); and agenesis of the corpus callosum (ACC; OMIM 304100) (CHIDSEY et al., 2014) . Mutations in L1CAM have also been reported to be associated with Hirschsprung disease (JACKSON et al., 2009 ). The incidence is 1 in 30,000 male births (SCHRANDER-STUMPEL and FRINS, 1998) . The clinical symptoms are highly variable, both within and between families (BURTON, 1979; HALLIDAY et al., 1986; FINCKH et al., 2000) and the mild ventricular enlargement is consistent with long survival whereas onset of fetal hydrocephalus during pregnancy (in utero) results in stillbirth or early infant mortality. The degrees of mental retardation and spasticity are also highly inconsistent. In almost 50% of observed cases, adducted thumbs are present but cannot be relied on as a diagnostic sign (HALLIDAY et al., 1986; KENWRICK et al., 1996) . Since 1949, when BICKERS and ADAMS (1949) described the first family with hydrocephalus and aqueduct stenosis in seven male relatives it was first thought that the hydrocephalus is caused by congenital stenosis of the aqueduct of Sylvius. STEVENS et al., (1993) bring the observation that it may rather be the result than the cause of hydrocephalus giving a motivation that aqueduct stenosis has also been reported in patients with hydrocephalus of other origin. The identification of the disease gene (L1CAM) and the mutation analyses have contributed to more accurate diagnostic procedures and to a better understanding of disease spectrum and pathogenesis.
Clinical Report
The couple was passed through our Genetic Counseling, during clinical diagnostic procedure in 3 years old son, due to presence of multiple malformations [hydrocephalus, agenesis of corpus callosum, tetraparesys, axial hypotony, cognitive and motor incompetency] requested after hospitalization. The proband was the first male child of a healthy, non consanguineous Italian couple with no known family history of brain abnormalities, recurrent miscarriages, other birth defects and/or genetic illnesses.
The proband was delivered at 36 weeks + 3days gestation by programed cesarean section after routine US control, performed in 33° g.w. when triventricular hydrocephalus was established. Until this moment, the pregnancy was completely uneventful and no positive US signs have been observed. The birth weight of 3.380 kg (90 th centile), length of 51 cm (90 th centile), and head circumference of 42 cm (>100 th centile -macrocefalia). APGAR scores were 6/10 at 1'/5', respectively. Post-natal Computed Tomography was performed at 2 nd day of age and results were consistent with a primary diagnosis of hydrocephalus with aqueductal (Sylvius) stenosis massive triventricular dilation, absence of corpus callosum. Due to this findings, a ventriculo-peritoneal shunt was placed at 4-day of age. Subsequently (at 9 months of age), magnetic resonance image (MRI) evidenced normal dimension of IV ventricle which was in axes and metallic artifact on the right side corresponding to external derivation of shunt with introduction of catheter. In supratentorial region, a multiple malformations have been seen (absence of corpus callosum, colpocephalyc dilatation of lateral ventricles with irregular configuration of walls, scarce representation of white matter and cortical atrophy particularly in parieto-occipital region ( Figure  1) .
The proband was evaluated in the medical genetics unit at 2 years and 9 months of age. His weight was 12 kg (10 th centile), hight was 87 cm (10 th centile). On physical examination, marked scaphocephaly was present, no adducted thumbs without contractures were noted ( Figure  1 ). The proband had no reported seizures. In medical documentation, presented during Genetic Counseling we had found:
Routine hemato-chemical laboratory examination (hepatic, renal, hormonal, martial, ecc.) were normal. ORL examination within normal limits. Ophthalmological examination: OO +1.75 sf. Nistagmus was present in all positions. Normal male karyotype (46, XY) was observed; aCGH whole genome chromosomal microarray analysis was pursued confirm no microdeletions/microduplications in this patient.
On the basis of medical documentation, anamnesis, clinical signs during Genetic Counseling a diagnostic hypotheses of L1 syndrome has been made, with subsequent explanation regarding genetic tests possibilities and consequences of eventually positive results of molecular test for the patient, his mother and for the mother's family. On the basis of our practice we fixed another appointment 2 weeks later, when collection of blood and signs of informed consensus should be performed, but unfortunately family has not shown up further.
Approximately one year later, the Department of Gynecology and Obstetrics requested Genetic Counseling for a 33 years old woman, secondigravida (22° gestation week), with abnormal ultrasound findings showing severe fetal ventriculomegaly. The family history was unremarkable with no consanguinity; she was one of two sisters and had a healthy brother. Surprisingly the woman was the mother of our proband, who was without any genetic testing. MR -mid-sagital (medial) section; f. MR -frontal (coronal) section; g. Pedigree after 1° Genetic Counseling; h,i. II pregnancy -ecography 22w+3d -ventriculomegaly; j. Pedigree after 2° Genetic Counseling and Genetic Tests results during II pregnancy; k. Pedigree after 3° Genetic Counseling and Genetic Test.
On the basis of the previous hypothesis of L1 syndrome, which become more probable after this clinical finding (see pedigree) we performed molecular analysis on proband's DNA, mother's DNA and fetal DNA, considering that no characterization was done at the moment of the first Genetic Counseling. The whole coding sequence of the L1CAM gene was analyzed by direct sequencing in an ABI 3730 DNA Analyzer (Applied Biosystems, Foster City, CA; conditions available on request). The alignment of the results with the sequences provided for L1CAM GeneBank accession number NM_000425 (NCBI, http://www.ncbi.nlm.nih.gov/) was carried out using the software SeqManII (DNASTAR. Madison, WI). This mutational screening revealed the presence in all the tested samples of the single nucleotide substitution c.2701C>T causing a stop codon at amino acid position 901 (p.Arg901*) in the exon 20 of the gene (Figure 2) . The same mutation has been already reported in three different L1 patients (MAC FARLANE et al., 1997; KANEMURA et al., 2006; VOS and HOFSTRA, 2010) and, as in our case, is generally associated to a severe phenotype. Conversely to our proband, adducted thumbs were diagnosed in all cases. From a functional point of view the substitution detected results in a loss of function of L1 protein due to a truncation within its 3rd Fn III domain. Genotype-phenotype correlation studies suggest that the type of mutation have an important effect on the severity of the L1 syndrome (BERTOLIN et al., 2010) . In general children with a loss of L1 protein were found more likely to die before the age of 3. On the basis of these results post-test Genetic Counseling has been performed with written report in which same genetic test for mother and subsequently for sister was recommended. Even these two cases (mother and sister of proband's mother) carried the same mutation in heterozygosis (Figure 1 and 2) and due to this observations other family members (grandaunts and cousins belonging to the branch of the maternal grandmother) should be analyzed. Since there are no predictive bio-markers for L1-syndrome, molecular analysis of the L1CAM gene is the only diagnostic tool for affected individuals and for the identification of healthy female carriers. In the same paper the authors (VOS and HOFSTRA, 2010) refer that in patients with three or more clinical characteristics but no affected relatives, the detection rate is around 58%. In the present study we identified L1CAM mutations in apparently sporadic cases with at least three disease features (hydrocephalus, agenesis of corpus callosum, tetraparesys, axial hypotony, cognitive and motor incompetency) and subsequently by the analysis of probands' relatives we evidenced several female carriers (see pedigree). This observation underline a necessity to consider L1-syndrome as potential part of differential diagnosis in all cases of hydrocephaly, same as undoubting of importance of pre-and post-test genetic counseling (BUKVIC and MARGAGLIONE, 2013; BUKVIC and ELLING, 2015; with subsequent, if necessary, extension of the molecular analysis to the relatives in order to provide an effective and reliable counseling and risk assessment to these families.
Finally, the development of new analytical tools [primarily next generation sequencing (NGS)] and development of an assay/gene panel can be used to specifically target a L1 Syndrome for fast, reliable and high quality results in tricky clinical situation like this one.
